Aripiprazole in the Treatment of Bipolar Depression

Completed · Not applicable

Conditions studied: Bipolar Disorder

In brief

A systematic open-label prospective pilot study to assess aripirazole for acute bipolar depression, with a secondary assessment of longer-term mood stabilization.

Key facts

Study ID

NCT00226317

Run by

Cambridge Health Alliance

People needed

20

Starts

2004-04-01

Expected to finish

2008-02-01

Last updated by the study team

2017-04-18

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• DSM-IV diagnosis of bipolar disorder, any subtype; MADRS >16; MRS < 10; not currently taking other mood stabilizers; women of reproductive potential must use an acceptable method of birth control

You may not qualify if…

• Current substance abuse within past month; serious unstable medical condition; active suicidal ideation; pregnant, trying to become pregnant, or nursing; intent to continue or initiate herbal preparations

Where it is running

• Cambridge Health Alliance — Cambridge, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.